We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

23 hedge funds and large institutions have $2.92M invested in NKGen Biotech, Inc. Warrants in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+23
Holders Change %
–
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
–
Reduced
–
Closed
–
Calls
$22K
Puts
–
Net Calls
+$22K
Net Calls Change
+$22K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$227K
2
AA
AQR Arbitrage
Connecticut
+$163K
3
RCM
Radcliffe Capital Management
Pennsylvania
+$150K
4
6CM
683 Capital Management
New York
+$125K
5
FTCM
Fir Tree Capital Management
New York
+$125K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.16M +$150K +120,000 New
HCM
2
Highbridge Capital Management
New York
$341K – – –
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$211K +$227K +181,900 New
AA
4
AQR Arbitrage
Connecticut
$151K +$163K +130,528 New
6CM
5
683 Capital Management
New York
$116K +$125K +100,000 New
FTCM
6
Fir Tree Capital Management
New York
$116K +$125K +100,000 New
SCC
7
Spring Creek Capital
Kansas
$107K +$115K +92,040 New
Balyasny Asset Management
8
Balyasny Asset Management
Illinois
$93K +$99.9K +80,000 New
TCA
9
Taconic Capital Advisors
New York
$81K +$87.4K +70,000 New
SCM
10
Shaolin Capital Management
Florida
$70K +$63.3K +50,678 New
PAMP
11
Polar Asset Management Partners
Ontario, Canada
$70K +$74.9K +60,000 New
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$58K +$62.5K +50,000 New
RCM
13
Rivernorth Capital Management
Florida
$46K +$50K +39,998 New
AIMCA
14
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$46K +$50K +40,000 New
JG
15
Jefferies Group
New York
$40.6K +$43.7K +35,000 New
ACM
16
Atalaya Capital Management
New York
$35K +$37.5K +30,000 New
CH
17
CVI Holdings
Delaware
$35K +$37.5K +30,000 New
NRCM
18
Northern Right Capital Management
Connecticut
$35K +$37.5K +30,000 New
GF
19
Gabelli Funds
New York
$23K +$25.1K +20,079 New
SC
20
Sculptor Capital
New York
$22K +$25K +20,000 New
GCIA
21
Gabelli & Co Investment Advisers
New York
$20K +$21.5K +17,240 New
EAM
22
Exos Asset Management
New York
$16K +$17.5K +14,000 New
CCM
23
CAAS Capital Management
New York
$12K – – –
EIP
24
Easterly Investment Partners
Massachusetts
$12K +$12.5K +10,000 New
Walleye Capital
25
Walleye Capital
New York
$12 +$13.1K +10,480 New

NKGNW Hedge Fund Activity: Q3 2021 in Review

23 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q3 2021, worth a combined $2.92M.

Buyers outnumbered sellers: 23 funds opened new NKGNW positions and 0 closed out — a net gain of 23 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $227K.

  • 23 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $2.92M of NKGen Biotech, Inc. Warrants stock for Q3 2021.
  • 23 funds opened new NKGen Biotech, Inc. Warrants positions in Q3 2021 and 0 closed out, a net change of +23 holders.
  • The largest NKGen Biotech, Inc. Warrants buyer in Q3 2021 was Adage Capital Partners, an estimated $227K added.

Based on aggregated 13F filings for Q3 2021.